Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease

被引：9
|
作者：
Kim, J. B. [1 ]
Liakopoulou, E. [2 ]
Watson, J. S. [1 ]
机构：
[1] Wythenshawe Hosp, Dept Plast Surg, Manchester M23 9LT, Lancs, England
[2] Christie Hosp NHS Trust, Dept Haematol, Manchester M20 4BX, Lancs, England
来源：
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY | 2008年 / 61卷 / 10期
关键词：
Chronic; Contractures; Cutaneous; Graft versus host disease; Joint; Surgical management;
D O I：
10.1016/j.bjps.2007.03.036
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Sclerodermatous or cutaneous chronic graft versus host disease is characterised by deposition of collagen in the skin and possibly other soft tissues, resulting in loss of range of motion and functional capabilities. A patient with refractory joint contractures caused by sclerodermatous graft versus host disease is presented, and the successful surgical management of the case described. (C) 2007 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：1235 / 1238
页数：4
相关论文
共 50 条
  • [11] Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective
    Moles-Poveda, P.
    Montesinos, P.
    Sanz-Caballer, J.
    de Unamuno, B.
    Pinana, J. L.
    Sahuquillo, A.
    Botella-Estrada, R.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (03): : 241 - 247
  • [12] Therapeutic experience on multiple contractures in sclerodermoid chronic graft versus host disease
    Choi, In-Sung
    Jang, In-Sub
    Han, Jae-Young
    Kim, Jae-Hyung
    Lee, Sam-Gyu
    SUPPORTIVE CARE IN CANCER, 2009, 17 (07) : 851 - 855
  • [13] Therapeutic experience on multiple contractures in sclerodermoid chronic graft versus host disease
    In-Sung Choi
    In-Sub Jang
    Jae-Young Han
    Jae-Hyung Kim
    Sam-Gyu Lee
    Supportive Care in Cancer, 2009, 17 : 851 - 855
  • [14] Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease
    Melgarejo-Ortuno, Alejandra
    Escudero-Vilaplana, Vicente
    Luis Revuelta, Jose
    Bailen, Rebeca
    Collado-Borrell, Roberto
    Gomez-Centurion, Ignacio
    Oarbeascoa, Guillen
    Kwon, Mi
    Heranz, Ana
    Luis Diez-Martin, Jose
    Sanjurjo, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 751 - 755
  • [15] Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease
    Assouan, Deborah
    Lebon, Delphine
    Charbonnier, Amandine
    Royer, Bruno
    Marolleau, Jean-Pierre
    Gruson, Berengere
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 687 - 689
  • [16] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [17] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [18] Novel therapeutics for the treatment of graft-versus-host disease
    Jacobsohn, DA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (09) : 1271 - 1280
  • [19] Successful treatment with hydrogen rich water in a case of chronic graft-versus-host-disease
    Qian, Li-ren
    Shen, Jian-liang
    MEDICAL GAS RESEARCH, 2016, 6 (03): : 177 - 179
  • [20] Tocilizumab for steroid refractory acute graft-versus-host disease
    Roddy, Julianna V. F.
    Haverkos, Bradley M.
    McBride, Ali
    Leininger, Kathryn M.
    Jaglowski, Samantha
    Penza, Sam
    Klisovic, Rebecca
    Blum, William
    Vasu, Sumithira
    Hofmeister, Craig C.
    Benson, Don M.
    Andritsos, Leslie A.
    Devine, Steven M.
    Efebera, Yvonne A.
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 81 - 85
12345